Anzeige
Mehr »
Login
Samstag, 04.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
InnoCan Pharma: Multi-Milliarden-Wert in diesem Pennystock?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
65 Leser
Artikel bewerten:
(0)

Global Autoimmune Disease Diagnostics Market 2016-2020 - Discovery of Novel Biomarkers Drives the Market - Research and Markets

DUBLIN, July 6, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global Autoimmune Disease Diagnostics Market 2016-2020" report to their offering.

The global autoimmune disease diagnostics market to grow at a CAGR of 6.39% during the period 2016-2020.

Global Autoimmune Disease Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

A trend contributing to market growth is the shift from monoplex to multiplex testing. The focus on multiplex testing is increasing, particularly in the area of in vitro diagnostics. Singleplex systems can analyze a single analyte from test samples for disease diagnosis. On the other hand, multiplexed assays can analyze samples by detecting multiple analytes from a single or multiple samples, offering a high-throughput solution. These multiplexed systems are cost-effective, require limited labor, and have increased efficiency and turnaround time in the delivery of results.

According to the report, a key growth driver is the discovery of novel biomarkers. Autoimmune diseases are of various types, with each individual exhibiting different symptoms if affected by at least two disease types. This makes it difficult for physicians to diagnose disease types. Biomarkers linked to autoimmune diseases are currently being discovered and studied, which has led to the development of biomarker-specific new diagnostic products. For instance, in 2013, researchers in the University of Cincinnati, US, identified various protein-based biomarkers associated with inflammatory bowel diseases such as Crohn's disease and ulcerative colitis.

Further, the report states that one challenge that could restrict market growth is the lack of skilled lab technicians.

Key vendors

- Abbott Laboratories

- Beckman Coulter

- Bio-Rad Laboratories

- Inova Diagnostics

- Siemens Healthcare

- Thermo Fisher Scientific

Other prominent vendors

- AESKU Diagnostics

- Alere

- Autoimmune Technologies

- Bio-Diagnostics

- bioMérieux

- Diarect

- DiaSorin

- Erba Diagnostics

- Euro Diagnostica

- EUROIMMUN

- Exagen Diagnostics

- Gold Standard Diagnostics

- HUMAN Diagnostics

- ImmunArray

- KRONUS

- Menarini

- Myriad Genetics

- Omega Diagnostics

- ORGENTEC Diagnostika

- Protagen

- Qiagen

- Quest Diagnostics

- Roche Diagnostics

- Seramun Diagnostica

- SQI Diagnostics

- Tecan

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by product

Part 07: Market segmentation by disease type

Part 08: Geographical segmentation

Part 09: Market drivers

Part 10: Impact of drivers

Part 11: Market challenges

Part 12: Impact of drivers and challenges

Part 13: Market trends

Part 14: Vendor landscape

Part 15: Major vendors

For more information visit http://www.researchandmarkets.com/research/prdl48/global_autoimmune

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.